MedTrace Logo

Node and Atrial Fibrillation Ablation for Persistent Atrial Fibrillation

NCT01057485 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2010-05-26

No results posted yet for this study

Summary

The purpose of the study is to assess combining AF ablation, with AV node ablation and pacemaker implantation for patients suffering with 'irregular heartbeats' or atrial fibrillation. The study will last 13 months.

Conditions

  • Persistent Atrial Fibrillation

Interventions

PROCEDURE

AF ablation and AV node ablation

AF ablation and AV node ablation

PROCEDURE

AV node ablation

AV node ablation

Sponsors & Collaborators

  • Eastbourne General Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2011-01-31
Completion
2012-01-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01057485 on ClinicalTrials.gov